表紙
市場調査レポート

米国の感染症検査市場:2015〜2019年

Infectious Disease Testing Market in the US 2015-2019

発行 TechNavio (Infiniti Research Ltd.) 商品コード 350013
出版日 ページ情報 英文 66 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。
Back to Top
米国の感染症検査市場:2015〜2019年 Infectious Disease Testing Market in the US 2015-2019
出版日: 2016年01月06日 ページ情報: 英文 66 Pages
概要

米国の感染症検査市場は2014〜2019年にかけCAGR5.81%で拡大すると予測されています。CDCによると、米国ではHIV感染者が120万人を超えています。2013年には47,352名の米国人がHIV感染と診断され、26,688名がAIDSと診断されました。

レポートでは、米国の感染症検査市場について調査し、同市場の現状と成長見通し、技術別、製品別動向、主要ベンダーの分析などをまとめています。

第1章 エグゼクティブサマリー

第2章 当レポートの範囲

第3章 市場調査方法

第4章 イントロダクション

第5章 市況

第6章 米国における感染症動向

  • 米国における償還
  • 米国FDAからの臨床試験所改善に対する免除
  • ファイブフォース分析

第7章 技術別市場セグメンテーション

  • 分子診断検査
  • 感染症のためのPOCT
  • 免疫診断検査

第8章 用途別市場セグメンテーション

第9章 製品別市場セグメンテーション

  • 装置
  • 消耗品

第10章 市場促進因子

第11章 促進因子の影響

第12章 市場の課題

第13章 促進因子と課題の影響

第14章 市場動向

第15章 ベンダー環境

第16章 主要ベンダー分析

  • Abbott Diagnostics
  • Alere
  • Beckman Coulter
  • Roche Diagnostics
  • Siemens Healthcare

第17章 付録

第18章 Technavioについて

図表

目次
Product Code: IRTNTR8448

About infectious disease testing

Infectious diseases are caused by microorganisms such as viruses, bacteria, fungi, and parasites. Infectious diseases are one of the primary contributors to morbidity and mortality worldwide. According to the CDC, in the US there are more than 1.2 million people living with HIV infection and one in eight are unaware about their condition. In 2013, it was estimated that 47,352 Americans were diagnosed with HIV infection and in the same year 26,688 people were diagnosed with AIDS. Early diagnosis and treatment play an important role to prevent the long-term complications of HIV/AIDS. Molecular testing, POCT, and immunodiagnostics are used for the screening and detection the disease. Infectious diseases increasingly threaten public health and contribute significantly to the rising costs of health care.

Manufacturers are developing diagnostic tests that can provide results in just a few minutes. For example, Alere developed Alere BinaxNOW Influenza A&B Card, which can detect influenza A & B in 15 minutes.

Technavio's analysts forecast the infectious disease testing market in the US to grow at a CAGR of 5.81% over the period 2014-2019.

Covered in this report

The report covers the current scenario and the growth prospects of the infectious disease testing market in the US for the period of 2015-2019. To calculate the market size, we consider the revenue generated from the sales of equipment and consumables from molecular diagnostics, POCT diagnostic devices, and immunodiagnostics, which are used to detect infectious diseases:

The market is segmented based on technology:

  • Molecular diagnostic test
  • POCT
  • Immunodiagnostic test

The POCT for infectious disease is further segmented based on application:

  • HIV
  • Respiratory
  • HAIs
  • Sexual health
  • Tropical diseases
  • Hepatitis

In addition, the market is segmented based on products:

  • Equipment
  • Consumables

Technavio's report, Infectious Disease Testing Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report presents the vendor landscape and a corresponding detailed analysis of the five key vendors in the market. The vendor landscape focuses on vendors that provide access to new technologies. The report also outlines the challenges faced by vendors and the market at large, as well as the key trends emerging in the market.

Key vendors

  • Abbott Diagnostics
  • Alere
  • Beckman Coulter Diagnostics
  • Roche
  • Siemens Healthcare

Other Prominent Vendors

  • Abaxis
  • Acon Laboratories
  • Avioq
  • BD
  • Bio-Rad Laboratories
  • Cavidi
  • Cepheid
  • Chembio Diagnostic Systems
  • Clarity Diagnostics
  • EMD Millipore
  • Epitope Diagnostic
  • Gold Standard Diagnostics
  • Hologic
  • Immunetics
  • InBios International
  • Life Technologies
  • Maxim Biomedical
  • Mindray
  • OraSure Technologies
  • Ortho Clinical Diagnostics
  • Quidel Corporation
  • Thermo Fisher Scientific
  • Trinity Biotech

Market driver

  • North America free trade agreement
  • For a full, detailed list, view our report

Market challenge

  • Medical device excise tax law
  • For a full, detailed list, view our report

Market trend

  • Development of innovative diagnostics initiatives
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview

PART 06: Infectious disease landscape in the US

  • Reimbursement in US
  • Clinical laboratory improvement amendments (CLIA) waiver from US Food and Drug Administration
  • Five forces analysis

PART 07: Market segmentation by technology

  • Molecular diagnostic test
  • POCT for infectious diseases
  • Immunodiagnostic tests

PART 08: Market segmentation by application

PART 09: Market segmentation by product

  • Equipment
  • Consumables

PART 10: Market drivers

  • NAFTA
  • Demand for rapid and automated diagnostics
  • Shift toward patient-centered model
  • Focus on disease management

PART 11: Impact of drivers

PART 12: Market challenges

  • Medical device excise tax law
  • Increase in globalization
  • New microbial diseases

PART 13: Impact of drivers and challenges

PART 14: Market trends

  • Development of innovative diagnostics initiatives
  • Key role of US Army Medical Research Institute in Diagnostics and Development (USAMRIID)
  • Low-cost microfluidic devices for POCT
  • Focus on early diagnosis of infectious diseases

PART 15: Vendor landscape

  • Competitive scenario
  • Abbott Diagnostics
  • Alere
  • Roche Diagnostics
  • Siemens Healthcare
  • Beckman Coulter Diagnostics
  • Other prominent vendors

PART 16: Key vendor analysis

  • Abbott Diagnostics
  • Alere
  • Beckman Coulter
  • Roche Diagnostics
  • Siemens Healthcare

PART 17: Appendix

  • List of abbreviations

PART 18: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Infectious disease testing market in US 2014-2019 ($ billions)
  • Exhibit 03: Average Medicare payments for infectious diseases
  • Exhibit 04: Five forces analysis
  • Exhibit 05: Segmentation of infectious disease testing market in US based on technology
  • Exhibit 06: Molecular diagnostic testing market in US 2014-2019 ($ billions)
  • Exhibit 07: POCT diagnostic testing market for infectious diseases in US 2014-2019 ($ billions)
  • Exhibit 08: Immunodiagnostic tests for infectious disease market in US 2014-2019 ($ billions)
  • Exhibit 09: Segmentation of infectious disease market in US by technology 2014
  • Exhibit 10: POCT for infectious diseases market in US by application
  • Exhibit 11: Segmentation of POCT for infectious disease market in US 2014
  • Exhibit 12: Infectious disease testing market in US by product
  • Exhibit 13: Segmentation of infectious disease testing market in US by product 2014
  • Exhibit 14: Impact of drivers
  • Exhibit 15: Impact of drivers and challenges
  • Exhibit 16: Key Takeaways: Abbott Diagnostics
  • Exhibit 17: Key takeaways: Alere
  • Exhibit 18: Key takeaways: Roche Diagnostics
  • Exhibit 19: Key takeaways: Siemens Healthcare
  • Exhibit 20: Key takeaways: Beckman Coulter Diagnostics
  • Exhibit 21: Abbott Diagnostics: Key business offerings
  • Exhibit 22: Alere: Business segmentation by revenue 2014
  • Exhibit 23: Alere: Business segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 24: Alere: Geographical segmentation comparison by revenue 2013 and 2014 ($ millions)
  • Exhibit 25: Beckman Coulter: Business segmentation
  • Exhibit 26: Roche Diagnostics: Business segmentation by revenue 2014
  • Exhibit 27: Roche Diagnostics: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 28: Roche Diagnostics: Segmentation of revenue by regions 2014
  • Exhibit 29: Siemens Healthcare: Business segmentation
  • Exhibit 30: Siemens Healthcare: Segmentation of revenue by geography 2014
Back to Top